Pancreatic cancer is one of the hardest cancers to treat. It often grows quietly, causing few symptoms until it has spread to other parts of the body.
Because it is usually found late and responds poorly to many treatments, scientists have been searching for better ways to help the immune system fight this disease.
A new study from the University of Minnesota Medical School offers fresh hope by explaining why pancreatic cancer can stay hidden from the body’s natural defenses. The findings were published in the journal Science Immunology.
The immune system constantly looks for cells that do not belong in the body or have become dangerous.
Special immune cells called T cells can recognize and destroy infected or cancerous cells before they grow out of control. However, many cancers develop clever ways to avoid being seen, allowing them to continue growing.
In this study, the researchers found that some pancreatic cancer cells switch off a normal process that helps the immune system recognize them. Without this signal, the cancer cells become almost invisible to immune cells. Once hidden, they are much more likely to survive, grow, and spread to other organs.
The team also discovered that another group of immune cells, called regulatory T cells, makes the problem even worse. These cells normally help prevent the immune system from attacking healthy tissues. In pancreatic cancer, however, they block other helpful T cells from destroying the hidden cancer cells.
The researchers wanted to find a way around these defenses. They tested a combination of two treatment strategies in preclinical models. One treatment restored the cancer cells’ visibility so the immune system could recognize them again, while the second treatment boosted the activity of CD4 helper T cells, an important type of immune cell that helps organize the body’s defense against disease.
The combined treatment produced much stronger immune responses than either approach alone. Once the cancer cells became visible again, the activated CD4 helper T cells helped direct a broader attack against the tumor. As a result, the cancer became less able to spread.
For many years, cancer researchers mainly focused on another type of immune cell called CD8 killer T cells because they directly destroy cancer cells. This study suggests that CD4 helper T cells may play a much larger role in pancreatic cancer than previously believed. These cells appear to coordinate and strengthen the entire immune response, making other immune cells work more effectively.
Senior author Dr. Ingunn Stromnes said the findings change the way scientists think about designing immunotherapy for pancreatic cancer. Instead of activating only one part of the immune system, future treatments may need to both expose hidden cancer cells and strengthen the teamwork between different immune cells.
The researchers now hope to learn exactly how CD4 helper T cells control these protective responses and how this knowledge can be turned into new treatments for patients. Although these findings are still at the preclinical stage, they provide an important foundation for future clinical studies.
This research offers new hope for one of the deadliest forms of cancer. However, because the work has not yet been tested in large human clinical trials, more research is needed before patients can benefit directly.
If future studies confirm these results, combining therapies that reveal hidden cancer cells with treatments that strengthen CD4 helper T cells could become a powerful new way to improve immunotherapy for pancreatic cancer.
If you care about cancer, please read studies that artificial sweeteners are linked to higher cancer risk, and how drinking milk affects risks of heart disease and cancer.
For more health information, please see recent studies about the best time to take vitamins to prevent heart disease, and results showing vitamin D supplements strongly reduces cancer death.
Source: University of Minnesota Medical School.
